BG106679A - Хиназолинови и нафтиридинови карбоксилни киселинис антибактериално действие - Google Patents

Хиназолинови и нафтиридинови карбоксилни киселинис антибактериално действие Download PDF

Info

Publication number
BG106679A
BG106679A BG106679A BG10667902A BG106679A BG 106679 A BG106679 A BG 106679A BG 106679 A BG106679 A BG 106679A BG 10667902 A BG10667902 A BG 10667902A BG 106679 A BG106679 A BG 106679A
Authority
BG
Bulgaria
Prior art keywords
dihydro
oxo
cyclopropyl
methoxy
acid
Prior art date
Application number
BG106679A
Other languages
Bulgarian (bg)
English (en)
Inventor
Steven Elmore
Curt COOPER
Colleen SCHULTZ
Douglas HUTCHINSON
Pamela DONNER
Brian Green
David Anderson
Qinghua Xie
Jurgen Dinges
Linda LYNCH
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of BG106679A publication Critical patent/BG106679A/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
BG106679A 1999-11-05 2002-05-09 Хиназолинови и нафтиридинови карбоксилни киселинис антибактериално действие BG106679A (bg)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US43529799A 1999-11-05 1999-11-05
US70533200A 2000-11-03 2000-11-03
PCT/US2000/030551 WO2001032655A2 (fr) 1999-11-05 2000-11-06 Antibacteriens a base d'acide quinoline carboxylique et d'acide naphthyridine carboxylique

Publications (1)

Publication Number Publication Date
BG106679A true BG106679A (bg) 2003-01-31

Family

ID=27030507

Family Applications (1)

Application Number Title Priority Date Filing Date
BG106679A BG106679A (bg) 1999-11-05 2002-05-09 Хиназолинови и нафтиридинови карбоксилни киселинис антибактериално действие

Country Status (12)

Country Link
EP (1) EP1226146A2 (fr)
JP (1) JP2003524633A (fr)
AR (1) AR030537A1 (fr)
AU (1) AU1468901A (fr)
BG (1) BG106679A (fr)
BR (1) BR0010728A (fr)
CZ (1) CZ20021531A3 (fr)
HK (1) HK1047287A1 (fr)
IL (1) IL148738A0 (fr)
MX (1) MXPA02004474A (fr)
NO (1) NO20022156L (fr)
WO (1) WO2001032655A2 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002018345A1 (fr) * 2000-08-29 2002-03-07 Chiron Corporation Composes de quinoline antibacteriens et procedes d'utilisation de ceux-ci
WO2002088298A1 (fr) 2001-04-27 2002-11-07 The Procter & Gamble Company Composes, compositions et procedes permettant de reguler des films biologiques
US8163769B2 (en) 2002-03-12 2012-04-24 Abbott Laboratories Antibacterial compounds
MXPA05009688A (es) * 2003-03-12 2005-12-05 Abbott Lab Derivados de naftiridina como agentes antibacterianos.
EP1829869A1 (fr) * 2006-03-02 2007-09-05 Laboratorios Del Dr. Esteve, S.A. Dérivés de 4,5,6,7-tétrahydrobenzo[b]thiophène et leur utilisaton comme ligands du récepteur sigma
US20080139574A1 (en) 2006-11-30 2008-06-12 Cadila Healthcare Limited Novel quinoline derivatives
TWI498115B (zh) * 2007-12-27 2015-09-01 Daiichi Sankyo Co Ltd 咪唑羰基化合物
SG10201510665WA (en) 2009-12-04 2016-01-28 Sunovion Pharmaceuticals Inc Multicycle Compounds And Pharmaceutical Compositions Useful For The Treatment Of Neurological Disorders
MA45795A (fr) 2016-07-29 2019-06-05 Sunovion Pharmaceuticals Inc Composés et compositions, et utilisations associées
IL264446B1 (en) 2016-07-29 2024-05-01 Pgi Drug Discovery Llc Compounds and compositions and their use
IL268694B2 (en) 2017-02-16 2023-10-01 Sunovion Pharmaceuticals Inc Treatment of schizophrenia
BR112020001433A2 (pt) 2017-08-02 2020-07-28 Sunovion Pharmaceuticals Inc. compostos de isocromano e usos dos mesmos
KR20200122345A (ko) 2018-02-16 2020-10-27 선오비온 파마슈티컬스 인코포레이티드 염, 결정 형태 및 이들의 제조 방법
CA3130849A1 (fr) 2019-03-14 2020-09-17 Sunovion Pharmaceuticals Inc. Sels d'un compose d'isochromanyle et formes cristallines, procedes de preparation, utilisations therapeutiques et compositions pharmaceutiques associees
KR20230003503A (ko) 2020-04-14 2023-01-06 선오비온 파마슈티컬스 인코포레이티드 신경학적 및 정신의학적 장애의 치료를 위한 (S)-(4,5-디히드로-7H-티에노[2,3-c]피란-7-일)-N-메틸메탄아민

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4665079A (en) * 1984-02-17 1987-05-12 Warner-Lambert Company Antibacterial agents

Also Published As

Publication number Publication date
MXPA02004474A (es) 2002-11-07
BR0010728A (pt) 2004-02-17
AR030537A1 (es) 2003-08-27
JP2003524633A (ja) 2003-08-19
EP1226146A2 (fr) 2002-07-31
CZ20021531A3 (cs) 2002-09-11
AU1468901A (en) 2001-05-14
NO20022156D0 (no) 2002-05-06
NO20022156L (no) 2002-07-04
WO2001032655A2 (fr) 2001-05-10
WO2001032655A3 (fr) 2002-01-24
HK1047287A1 (zh) 2003-02-14
IL148738A0 (en) 2002-09-12

Similar Documents

Publication Publication Date Title
US5366972A (en) 5,11-dihydro-6H-dipyrido(3,2-B:2',3'-E)(1,4)diazepines and their use in the prevention or treatment of HIV infection
BG106679A (bg) Хиназолинови и нафтиридинови карбоксилни киселинис антибактериално действие
AU2010340142B2 (en) Quinoline amide M1 receptor positive allosteric modulators
JP4058106B2 (ja) 抗菌性のピペリジン誘導体
US20040087577A1 (en) Anti-infective agents
AU2007250560B2 (en) Nicotinic acetylcholine receptor ligands 101
US20020049223A1 (en) Quinoline and naphthyridine carboxylic acid antibacterials
WO2017001307A1 (fr) Nouvelle aminothiazolopyrimidinedione substituée pour le traitement et la prophylaxie d'une infection virale
TW200536849A (en) Substituted heterocycles and the uses thereof
AU2008345560A1 (en) Benzofuropyrimidinones as protein kinase inhibitors
US7723523B2 (en) Tetrahydropyridothiophenes
AU2003248592A1 (en) Biaryl diazabicycloalkane amides as nicotinic acetylcholine agonists
KR20090015066A (ko) Ｃ-ｆｍｓ 키나제의 저해제
EA003607B1 (ru) 4-ОКСО-4,7-ДИГИДРОТИЕНО [2,3-b]ПИРИДИН-5-КАРБОКСАМИДЫ В КАЧЕСТВЕ АНТИВИРУСНЫХ СРЕДСТВ
MXPA06008787A (es) Derivados de 1h-tieno[2,3-c]pirazol utiles como inhibidores de cinasa.
CA2158225A1 (fr) Imidazopyridines
JP6110787B2 (ja) ピリミドジアゼピノン化合物
JP2009519337A (ja) 治療剤としてのｍＧｌｕＲ１アンタゴニスト
WO2008020045A1 (fr) Dérivés de tétrahydrobenzothiophène
US6303613B1 (en) Aminopyrimidine derivatives, processes for their preparation, compositions containing them and their use as pharmaceuticals
US8163769B2 (en) Antibacterial compounds
KR20110014710A (ko) 박테리아 감염의 치료를 위한 헤테로시클릭 우레아 유도체
WO2004055015A1 (fr) Inhibiteurs aminocyanopyridine de proteine kinase 2 activee par la proteine kinase activee par mitogene
US20080051463A1 (en) Anthracene compounds and their use for treating benign and malignant tumor disorders
JP2006514964A (ja) 抗菌剤としてのナフチリジン誘導体